Spots Global Cancer Trial Database for Routine Therapy Plus Moxifloxacin in Advanced Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Routine Therapy Plus Moxifloxacin in Advanced Breast Cancer
Official Title: Routine Therapy Plus Moxifloxacin in Advanced Breast Cancer
Study ID: NCT03405168
Interventions
Study Description
Brief Summary: This is a phase II,single center,prospective, single arm clinical trial. The objective is to evaluate the efficacy and safety of routine therapy plus moxifloxacin in Advanced Breast Cancer whose evaluation is stable disease with a trend of progression.
Detailed Description: This is a phase II,single center,prospective, single arm clinical trial. A lot of in vitro and in vivo study demonstrate that quinolones antibiotics can increase anti-tumor effect. The objective is to evaluate the efficacy and safety of routine therapy plus moxifloxacin in Advanced Breast Cancer whose evaluation is stable disease with a trend of progression.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Zhongyu Yuan, Guangzhou, Guangdong, China
Contact Details
Name: jiajia huang
Affiliation: Sun-yatsen University Cancer center
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
